172 related articles for article (PubMed ID: 32283712)
1. Inhibition of Kv10.1 Channels Sensitizes Mitochondria of Cancer Cells to Antimetabolic Agents.
Hernández-Reséndiz I; Pacheu-Grau D; Sánchez A; Pardo LA
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32283712
[TBL] [Abstract][Full Text] [Related]
2. Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin.
Hartung F; Pardo LA
Eur Biophys J; 2016 Oct; 45(7):709-719. PubMed ID: 27350552
[TBL] [Abstract][Full Text] [Related]
3. In vivo imaging of tumour xenografts with an antibody targeting the potassium channel K
Napp J; Pardo LA; Hartung F; Tietze LF; Stühmer W; Alves F
Eur Biophys J; 2016 Oct; 45(7):721-733. PubMed ID: 27444284
[TBL] [Abstract][Full Text] [Related]
4. Kv10.1 Regulates Microtubule Dynamics during Mitosis.
Movsisyan N; Pardo LA
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32854244
[TBL] [Abstract][Full Text] [Related]
5. APETx4, a Novel Sea Anemone Toxin and a Modulator of the Cancer-Relevant Potassium Channel K
Moreels L; Peigneur S; Galan DT; De Pauw E; Béress L; Waelkens E; Pardo LA; Quinton L; Tytgat J
Mar Drugs; 2017 Sep; 15(9):. PubMed ID: 28902151
[TBL] [Abstract][Full Text] [Related]
6. State-independent inhibition of the oncogenic Kv10.1 channel by desethylamiodarone, a comparison with amiodarone.
Gomez-Lagunas F; Barriga-Montoya C; Pardo JP
Pflugers Arch; 2024 Mar; 476(3):323-335. PubMed ID: 38063872
[TBL] [Abstract][Full Text] [Related]
7. Kv10.1 potassium channel: from the brain to the tumors.
Cázares-Ordoñez V; Pardo LA
Biochem Cell Biol; 2017 Oct; 95(5):531-536. PubMed ID: 28708947
[TBL] [Abstract][Full Text] [Related]
8. 3D Pharmacophore-Based Discovery of Novel K
Toplak Ž; Hendrickx LA; Gubič Š; Možina Š; Žegura B; Štern A; Novak M; Shi X; Peigneur S; Tytgat J; Tomašič T; Pardo LA; Mašič LP
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808994
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the K
Barriga-Montoya C; Huanosta-Gutiérrez A; Reyes-Vaca A; Hernández-Cruz A; Picones A; Gómez-Lagunas F
Pflugers Arch; 2018 Mar; 470(3):491-503. PubMed ID: 29218452
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine inhibits tumor-related Kv10.1 channel and decreases migration of MDA-MB-231 breast cancer cells in vitro.
Valdés-Abadía B; Morán-Zendejas R; Rangel-Flores JM; Rodríguez-Menchaca AA
Eur J Pharmacol; 2019 Jul; 855():262-266. PubMed ID: 31082369
[TBL] [Abstract][Full Text] [Related]
11. PIST (GOPC) modulates the oncogenic voltage-gated potassium channel KV10.1.
Herrmann S; Ninkovic M; Kohl T; Pardo LA
Front Physiol; 2013; 4():201. PubMed ID: 23966943
[TBL] [Abstract][Full Text] [Related]
12. New Diarylamine K
Gubič Š; Toplak Ž; Shi X; Dernovšek J; Hendrickx LA; Pinheiro-Junior EL; Peigneur S; Tytgat J; Pardo LA; Peterlin Mašič L; Tomašič T
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145712
[TBL] [Abstract][Full Text] [Related]
13. The N and C-termini of SPCA2 regulate differently Kv10.1 function: role in the collagen 1-induced breast cancer cell survival.
Girault A; Peretti M; Badaoui M; Hémon A; Morjani H; Ouadid-Ahidouch H
Am J Cancer Res; 2021; 11(1):251-263. PubMed ID: 33520372
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival.
Martínez R; Stühmer W; Martin S; Schell J; Reichmann A; Rohde V; Pardo L
BMC Cancer; 2015 Nov; 15():839. PubMed ID: 26530050
[TBL] [Abstract][Full Text] [Related]
15. KV10.1 K(+)-channel plasma membrane discrete domain partitioning and its functional correlation in neurons.
Jiménez-Garduño AM; Mitkovski M; Alexopoulos IK; Sánchez A; Stühmer W; Pardo LA; Ortega A
Biochim Biophys Acta; 2014 Mar; 1838(3):921-31. PubMed ID: 24269539
[TBL] [Abstract][Full Text] [Related]
16. Kv10.1 K(+) channel: from physiology to cancer.
Ouadid-Ahidouch H; Ahidouch A; Pardo LA
Pflugers Arch; 2016 May; 468(5):751-62. PubMed ID: 26743871
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent membrane potential assay for drug screening on Kv10.1 channel: identification of BL-1249 as a channel activator.
Gómez-Herrera MA; Patlán E; Estrada-Garrido A; Hernández-Cruz A; Luis E
Front Pharmacol; 2023; 14():1238503. PubMed ID: 37554982
[TBL] [Abstract][Full Text] [Related]
18. Behavioural and functional characterization of Kv10.1 (Eag1) knockout mice.
Ufartes R; Schneider T; Mortensen LS; de Juan Romero C; Hentrich K; Knoetgen H; Beilinson V; Moebius W; Tarabykin V; Alves F; Pardo LA; Rawlins JN; Stuehmer W
Hum Mol Genet; 2013 Jun; 22(11):2247-62. PubMed ID: 23424202
[TBL] [Abstract][Full Text] [Related]
19. Collagen type 1 promotes survival of human breast cancer cells by overexpressing Kv10.1 potassium and Orai1 calcium channels through DDR1-dependent pathway.
Badaoui M; Mimsy-Julienne C; Saby C; Van Gulick L; Peretti M; Jeannesson P; Morjani H; Ouadid-Ahidouch H
Oncotarget; 2018 May; 9(37):24653-24671. PubMed ID: 29872495
[TBL] [Abstract][Full Text] [Related]
20. Role of gamma radiation on functional expression of the voltage-gated potassium channel Kv10.1 and its importance in the radiobiological response.
Luis E; Lara Figueroa CO; Durán Pastén ML; Azorín Vega EP
Appl Radiat Isot; 2022 Sep; 187():110331. PubMed ID: 35764005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
